Exploratory study about the effect of silodosin on female voiding dysfunctio
- Conditions
- Voiding dysfunction
- Registration Number
- JPRN-UMIN000022024
- Lead Sponsor
- Dokkyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Not provided
1)severe heart disease 2)severe liver diseae or over 3mg/dl total bilirubin or over 2.5 times AST(GOT)o ALT(GPT) 3)severe kidney disease or over 1.5mg/dl creatinine 4)severe hypotention 5)women who are pregnant, breast-feeding, or seeking to conceive or may conceive due to improper contraception method during the study period 6)Patients receiving surgical therapy, which may influence the lower urinary tract function 7)Patients receiving nonpharmacologic therapy within 4 weeks prior to the study commencement, which may influence the lower urinary tract function 8)Patients who received an investigational drug in other clinical study within 1 month prior to the study commencement (the period of which should be calculated based on the date on which the investigational drug was administered) 9)Patients who are otherwise ineligible to take part in the study as judged by Principal Investigator or other relevant person
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method